PuSH - Publikationsserver des Helmholtz Zentrums München

Götzfried, J. ; Smirnova, N.F. ; Morrone, C. ; Korkmaz, B.* ; Yildirim, A.Ö. ; Eickelberg, O. ; Jenne, D.

Preservation with alpha(1)-antitrypsin improves primary graft function of murine lung transplants.

J. Heart Lung Transpl. 37, 1021-1028 (2018)
Verlagsversion Postprint Forschungsdaten DOI PMC
Open Access Gold (Paid Option)
Creative Commons Lizenzvertrag
BACKGROUND: Vascular damage and primary graft dysfunction increase with prolonged preservation times of transplanted donor lungs. Hence, storage and conservation of donated lungs in protein-free, dextran-containing electrolyte solutions, like Perfadex, is limited to about 6 hours. We hypothesized that transplanted lungs are protected against neutrophil-mediated proteolytic damage by adding alpha(1)-antitrypsin (AAT), a highly abundant human plasma proteinase inhibitor, to Perfadex.METHODS: A realistic clinically oriented murine model of lung transplantation was used to simulate the ischemia-reperfusion process. Lung grafts were stored at 4 degrees C in Perfadex solution supplemented with AAT or an AAT mutant devoid of elastase-inhibiting activity for 18 hours. We examined wild-type and proteinase 3/neutrophil elastase (PR3/NE) double-deficient mice as graft recipients. Gas exchange function and infiltrating neutrophils of the transplanted lung, as well as protein content and neutrophil numbers in the bronchoalveolar lavage fluid, were determined.RESULTS: AAT as a supplement to Perfadex reduced the extent of primary graft dysfunction and early neutrophil responses after extended storage for 18 hours at 4 degrees C and 4-hour reperfusion in the recipients. Double-knockout recipients that lack elastase-like activities in neutrophils were also protected from early reperfusion injury, but not lung grafts that were perfused with a reactive center mutant of AAT devoid of elastase-inhibiting activity.CONCLUSIONS: PR3 and NE, the principal targets of AAT, are major triggers of post-ischemic reperfusion damage. Their effective inhibition in the graft and recipient is a promising strategy for organ usage after storage for >6 hours. (C) 2018 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Primary Graft Dysfunction ; Ischemia-reperfusion Injury ; Alpha-1-antitrypsin ; Elastase ; Proteinase 3 ; Animal Models ; Lung Transplantation; Ischemia-reperfusion Injury; Neutrophil Serine Proteases; Inflammatory Response; Cell Apoptosis; Alpha-1-antitrypsin; Aprotinin; Elastase; Proteinase-3; Dysfunction; Inhibition
ISSN (print) / ISBN 1053-2498
e-ISSN 1557-3117
Zeitschrift Journal of Heart and Lung Transplantation, The
Quellenangaben Band: 37, Heft: 8, Seiten: 1021-1028 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort 360 Park Ave South, New York, Ny 10010-1710 Usa
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Lung Health and Immunity (LHI)